Pacira BioSciences has a Cash Ratio of 1.56. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Pacira BioSciences's Cash Ratio or its related term are showing as below:
PCRX'
s Cash Ratio Range Over the Past 10 Years
Min: 1.06 Med: 2.39 Max: 6.32
Current: 1.56
During the past 13 years, Pacira BioSciences's highest Cash Ratio was 6.32. The lowest was 1.06. And the median was 2.39.
PCRX's Cash Ratio is ranked better than 73.57% of 995
companies
in the Drug Manufacturers industry
Industry Median: 0.59
vs PCRX: 1.56
Pacira BioSciences Cash Ratio Historical Data
The historical data trend for Pacira BioSciences's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pacira BioSciences's Cash Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacira BioSciences's Cash Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Pacira BioSciences's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pacira BioSciences (NAS:PCRX) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Pacira BioSciences Cash Ratio Related Terms
Thank you for viewing the detailed overview of Pacira BioSciences's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PCRX has been successfully added to your 